We knew Dolly Parton was a living legend, but a contributor towards the cure for Covid-19?
Dolly Parton can add being an important coronavirus vaccine sponsor to her long list of achievements, including being an extraordinary singer, songwriter, Miley Cyrus' godmother, idol and many, many more.
Regardless of which vaccine "wins" the race to protect the public from the novel virus, two things are for certain: science is fantastic, and Dolly Parton f**king RULES!
The 74-year-old had in April posted via Instagram that she would donate US$1 million (RM4,096,500) to Vanderbilt University Medical Center in Nashville. Vanderbilt was involved with Moderna's work to develop the vaccine that reportedly has thus far shown almost 95% efficacy.
Dolly Parton - how much has she donated to fight COVID?
John Howser, a spokesman for the centre, has spoken out on how Dolly's generous donation is making a difference, with the money she gave going towards an early stage trial.
"His donation helped with a plasma study that one of our researchers eventually conducted successfully", a university spokesman told the BBC.
"I am making a donation of $1 million to Vanderbilt towards that research and to encourage people that can afford it to make donations".
This also isn't the first time Parton has given big bucks to medicine.
"Two of these antibodies are now being tested by a global pharmaceutical firm".
The pandemic has had the entire globe scrambling in order to find a solution to this deadly disease, which has killed over 200,000 Americans-even some North Dakotans who, according to one nurse, insisted that the disease wasn't real up until their dying breaths.
"My long-time friend, a doctor who did research at Vanderbildt for years Naji Abumrad told me that they are taking interesting advances in research aimed at finding a cure for the coronavirus. Keep the faith, Dolly". "But I just felt so proud to have been part of that little seed money that will hopefully grow into something great and help to heal this world". And the results have been VERY promising: so far, the vaccine shows an estimated 94.5% protection from the virus, according to The New York Times.
The news of its success rate followed similar findings from Pfizer's vaccine trials, which announced November 9 that its vaccine has shown to be 90% effective against the virus.
The UK government has already ordered millions of doses of the vaccine, and Health Secretary Matt Hancock suggested it could be available from Spring 2021.